Exagen Inc.
XGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,087 | -$4,439 | -$3,752 | -$3,761 |
| Dep. & Amort. | $612 | $466 | $440 | $415 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $443 | $417 | $433 |
| Change in WC | $5,963 | -$1,117 | -$8,126 | $2,936 |
| Other Non-Cash | $3,456 | $1,762 | $350 | $340 |
| Operating Cash Flow | $2,944 | -$2,885 | -$10,671 | $363 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$275 | -$209 | -$113 | -$146 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $6 | $0 |
| Investing Cash Flow | -$275 | -$209 | -$107 | -$146 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$535 | $3,155 | -$262 | -$216 |
| Stock Issued | $3,485 | $18,777 | $0 | $0 |
| Stock Repurch. | $0 | $1 | $198 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $2,950 | $21,933 | -$64 | -$216 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,619 | $18,839 | -$10,842 | $1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $30,033 | $11,394 | $22,236 | $22,235 |
| End Cash | $35,652 | $30,233 | $11,394 | $22,236 |
| Free Cash Flow | $2,669 | -$3,094 | -$10,784 | $217 |